Genome-wide miRNA Profiling in Myelodysplastic Syndrome with del(5q) Treated with Lenalidomide

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68407700%3A21230%2F15%3A00221070" target="_blank" >RIV/68407700:21230/15:00221070 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11110/15:10295618 RIV/00023736:_____/15:00011088 RIV/00064165:_____/15:10295618
Result on the web
<a href="http://onlinelibrary.wiley.com/doi/10.1111/ejh.12458/pdf" target="_blank" >http://onlinelibrary.wiley.com/doi/10.1111/ejh.12458/pdf</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1111/ejh.12458" target="_blank" >10.1111/ejh.12458</a>

Result language
angličtina
Original language name
Genome-wide miRNA Profiling in Myelodysplastic Syndrome with del(5q) Treated with Lenalidomide
Original language description
Lenalidomide is a potent drug with pleiotropic effects in patients with myelodysplastic syndrome (MDS) with deletion of the long arm of chromosome 5 [del(5q)]. We investigated its effect on regulation of microRNA (miRNA) expression profiles in del(5q) MDS patients in vivo.
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—

Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year
2015
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)